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Abstract 
Context: While previous studies have demonstrated an increase in blood pressure 
when measured while talking, the effect of conversation on the measurement of blood 
pressure using a BpTRU device is unknown. 
Objective: In adults who have their blood pressure measured using a BpTRU device in 
the primary care setting, does the presence of a healthcare professional engaging the 
patient in conversation during the measurement period affect the recorded blood 
pressure compared to the patient being alone in a private room and silent during the 
measurement period? 
Design: An assessment of two approaches of measuring blood pressure using a 
BpTRU device in which participants serve as their own control and the order of 
testing is randomized. 
Participants:  Adults (n=272) aged ≥ 19 years recruited from an academic family 
practice unit in St. John’s NL. 
Intervention: Participant’s blood pressure was measured twice using a BpTRU device, 
once while alone in a quiet room maintaining silence and once while engaging in a 
health-related conversation. Whether blood pressure was measured first during 
conversation or during silence was randomized. 
Outcome Measures: Systolic and diastolic blood pressure, and the mean difference in 
systolic and diastolic blood pressures between talking and silent measurement 
conditions.  
Results: Mean systolic blood pressure was 9 mmHg higher (95% CI 8.2 – 10.5) and 
mean diastolic blood pressure was 8 mmHg higher (95% CI 7.6 – 8.9) when measured 
during conversation compared to when measured in silence. Systolic and diastolic 
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blood pressure measured during conversation remained significantly higher after 
controlling for all other variables in multiple linear regression analysis. 
Conclusion: To avoid inaccurate measurement of blood pressure which could result in 
the overdiagnosis and overtreatment of hypertension, blood pressure measurement 
with the BpTRU device should be conducted with patients alone and in silence.  
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Chapter 1: Introduction 
Hypertension is common across Canada and globally. The current prevalence of 
hypertension in Canadian adults is between 20% and 27%1, 2, 3, 4. Hypertension is the 
leading global risk factor for death or disability5, and is a clinically important risk 
factor for cardiovascular disease including coronary heart disease, ischaemic and 
haemorrhagic stroke, heart failure, peripheral vascular disease, renal impairment and 
visual impairment6. Cardiovascular diseases have the highest financial health care cost 
of all diseases7 and are responsible for the greatest number of visits to family 
physicians in Canada, more than 20 million visits annually8. 
Hypertension is frequently diagnosed and managed in the primary care setting. In 
2007 the cost of hypertension-related physician visits, laboratory tests and prescribed 
medications in Canada was estimated to be almost $2.4 billion9. One estimate of the 
implications of inaccurate blood pressure measurement suggested that a 5 mmHg error 
in measurement of blood pressure would result in 21 million Americans being denied 
treatment for hypertension or 27 million being exposed to unnecessary treatment for 
hypertension, depending on the direction of the error10. The accurate measurement of 
blood pressure in the primary care setting therefore has great clinical and economic 
importance. 
In the past, blood pressure was traditionally measured manually in primary care using 
a mercury sphygmomanometer. However due to inaccuracy of manual blood pressure 
measurement in routine clinical practice, manual sphygmomanometers are being 
replaced in clinical practice by automated devices. The most common automated 
device used in Canada is the BpTRU (BpTRU Medical Devices, Coquitlam, British 
Columbia, Canada), with over 10,000 BpTRU devices currently in use in Canada11. 
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The BpTRU is a fully automated sphygmomanometer which measures blood pressure 
by the oscillometric method: an electronic sensor in the cuff measures deviations in 
the cuff pressure due to changes in arterial blood pressure. The BpTRU takes a single 
‘test’ reading to validate that a proper blood pressure measurement is being recorded, 
and then automatically takes five more blood pressure recordings at a predetermined 
interval. The mean of these subsequent five recordings is calculated and displayed as 
the blood pressure measurement. It has been shown that recordings taken at one-
minute intervals and two-minute intervals with the BpTRU result in a similar overall 
average measurement, leading to the recommendation that blood pressure can be 
measured with the BpTRU using the one-minute interval setting12. The operating 
instructions of the BpTRU device state that patients should be left alone in a quiet 
room while their blood pressure is measured.  
The BpTRU has been shown to be a valid blood pressure measurement instrument13, 
to be superior to manual blood pressure measurement in correlation with daytime 
ambulatory blood pressure monitoring (ABPM)14, 15, 16, and to eliminate the “white 
coat” response seen in clinical practice17, 18. BpTRU values and AABP values tend to 
correlate within 1 or 2 mmHg, whereas the difference between routine manual systolic 
office blood pressure measured in primary care and AABP can be as much as 10 to 20 
mmHg19. 
There is evidence from several studies showing that speaking during blood pressure 
measurement causes an increase in blood pressure readings20, 21, 22, 23, 24, 25, 26, 27. 
However, reports of the magnitude of this increase are varied, and evidence is of 
varying methodological quality. Most studies have been conducted using a manual 
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sphygmomanometer, and no studies have been published investigating whether this 
phenomenon is seen when blood pressure is measured using a BpTRU device.  
The purpose of this study is to investigate whether the recorded blood pressure using a 
BpTRU device is affected by someone being present in the room and engaging the 
patient in a health-related conversation during the measurement period, compared to 
measuring their blood pressure with the patient alone in a quiet room maintaining 
silence. 
 
Literature Review  
A 1980 study investigated the effect of quiet conversation on the blood pressure of 
twenty-four hypertensive patients20. The patient’s blood pressure was measured every 
two minutes for three consecutive eight-minute periods using an ultrasonic blood 
pressure meter. During the first eight-minute period, a doctor sat in front of the patient 
examining their medical notes but not speaking to them. During the second eight-
minute period the doctor engaged the patient in a quiet conversation regarding their 
blood pressure medication and any experienced side effects. The third eight-minute 
period was the same as the first period. The investigators found that mean systolic and 
diastolic blood pressure dropped gradually throughout the first period, rose sharply at 
the start of the second (conversation) period with a maximum rise of 20.8/11.6 mmHg, 
then dropped again during the third period to the same levels as the first period. They 
concluded that engaging a patient in conversation causes a rise in their blood pressure. 
However, the measurement procedure was not randomized, it is not clear how study 
participants were selected, the sample size was small, and the setup of the experiment 
did not simulate a modern-day clinical encounter well. 
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A 2017 study used a similar study design to investigate the effect of talking with a 
doctor on systolic and diastolic blood pressure21. The investigators measured the blood 
pressure of 200 outpatients (122 hypertensive and 78 normotensive) at defined 
intervals of before talking, during talking and after talking with a doctor. They used an 
oscillometric blood pressure monitor (Omron BP HEM 7201). The investigators found 
that systolic blood pressure increased significantly when measured after one minute of 
talking compared to the previous measurements recorded before talking, and then 
decreased quickly after talking was stopped and returned to baseline roughly five 
minutes later. The maximum rise in systolic BP was 9.1 mmHg and the maximum rise 
in diastolic BP was 4.5 mmHg. The authors state that during the talking phase of the 
study the doctor asked the participant some questions about the disease, but there is no 
indication in the paper that this conversation was standardized. Whether a sample size 
calculation was used is not mentioned, and it is unclear how participants for the study 
were selected. 
A similar study conducted in 1989 investigated the effects of low affect talking on the 
blood pressure of 37 patients with coronary heart disease22. Whilst in a room with a 
researcher and monitored by ECG and automated blood pressure recording, patients 
stood quietly for two minutes, spoke about their normal daily activities whilst standing 
for two minutes, then stood quietly for a further two minutes. The study found that 
mean blood pressure was significantly higher during the talking phase than the two 
silent phases, and that increasing age and higher resting systolic blood pressure were 
positively correlated with greater increases of systolic blood pressure during talking. 
This study has similar methodological flaws to those above, and the setup of the 
talking phase of the study almost simulates an exercise in public speaking. 
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Furthermore, these results can only be applied to patients with coronary heart disease, 
and the measurement of blood pressure in the standing position is not routine in 
clinical practice. A further study conducted by the same researchers found that the rise 
in diastolic blood pressure during talking was comparable to the rise in diastolic blood 
pressure during phase three exercise stress testing23. Another study published in 1992 
also reported a mean increase in systolic and diastolic blood pressure in 109 healthy 
participants whilst talking about their daily activities, measured using an oscillometric 
device24. 
A 1984 study investigated the effect of reading aloud from a card on the measurement 
of blood pressure using a mercury sphygmomanometer25. The investigators recruited 
48 patients from a hypertensive clinic and measured their diastolic blood pressure 
during silence, whilst the participant read from a card while the BP cuff was being 
inflated then stopped reading as the cuff was deflated, and while the participant read 
from a card during the whole measurement period. They found that diastolic blood 
pressure increased during reading, and concluded that talking increased the diastolic 
blood pressure by a clinically significant level. They do not mention any findings 
related to systolic blood pressure, and the conclusion of the study has been generalised 
to talking rather than reading aloud. 
A 2001 study assessed the blood pressure of 63 patients with essential hypertension 
using an automated auscultatory device during a sequence of silence, counting aloud, 
silence, stressful talking, and silence, with the phases of counting and talking being 
randomized26. The investigators found that during stressful talking the mean systolic 
blood pressure increased by 19 mmHg and the mean diastolic blood pressure 
increased by 13.3 mmHg compared to measured blood pressure during silence, and 
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this increase was of greater magnitude than between counting aloud and silence. The 
investigators also demonstrated similar effects of talking on the measurement of blood 
pressure in another study investigating the effects of talking and reading on blood 
pressure27. 
A 2012 study investigated the effect of speech on the measurement of blood pressure 
in 111 healthy individuals28. The researchers in this study reported an increase in 
systolic blood pressure of 5.3 mmHg and an increase in 6.2 mmHg diastolic blood 
pressure in talking conditions compared to resting conditions. However, they 
measured blood pressure using the auscultatory method and the talking phase in the 
study the participants was counting aloud as opposed to engaging in conversation. The 
results of this study therefore cannot be generalised to patients whose blood pressure 
is measured using a BpTRU device, and who are engaged in a health-related 
conversation.  
While there is a general consensus in the literature that speaking during blood pressure 
measurement results in an increase in recorded blood pressure, none of the above 
studies compared holding a health-related conversation during the measurement of 
blood pressure to measuring blood pressure while the patient is alone in a quiet room 
maintaining silence. There is evidence to suggest that leaving patients alone in a quiet 
room results in a reduction in their recorded blood pressure. In a study conducted 
using the BpTRU device, blood pressure readings taken at one-minute intervals after 
the examining doctor/nurse leaves the examining room show a rapid decrease in blood 
pressure29. About 75% of this decrease in blood pressure occurs within two minutes of 
the patient being left alone30.  
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The evidence in the literature suggests that blood pressure increases while talking, and 
it decreases when sitting alone in a quiet room. However, these two conditions of 
blood pressure measurement have never been formally compared, and the effect of 
conversation on the measurement of blood pressure has never been investigated when 
measured with a BpTRU device. As it has been shown that the BpTRU device 
effectively eliminates the “white coat” response, it is possible that the BpTRU could 
also eliminate the increase in blood pressure seen during conversation. 
Two recent studies have investigated whether there is a difference in blood pressure 
when measured with a BpTRU device in a quiet examining room or in a waiting room. 
The first was a pilot randomized controlled trial conducted in Toronto, Ontario, in 
201131. Fifty patients were recruited and randomly allocated to have their blood 
pressure measured using a BpTRU device either alone in a quiet examining room or in 
an open waiting area of the clinic. The authors found no significant difference in 
systolic or diastolic blood pressure between these measurement conditions, in 
hypertensive and normotensive participants. They did however find an order effect, 
with systolic blood pressure decreasing significantly between the first and second set 
of readings. Because of the small sample size, these findings can be considered 
preliminary only, and the authors state they will be used to plan a further study which 
has yet to be published. However, it does suggest that the order of blood pressure 
readings has a significant effect on the outcome, and measurement order will therefore 
be randomized and considered as an independent variable in this study. 
The second recent study investigating the effect of measurement conditions on blood 
pressure when measured using a BpTRU device was conducted in 2015 in Kingston, 
Ontario32. The investigators measured the blood pressure of 422 patients seen in a 
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hypertension specialty clinic, first in an examination room with a nurse present and 
then the following day in the clinic waiting room after they had returned from 24 
hours of ambulatory BP monitoring. The authors found that blood pressure was 
significantly higher when measured initially in the examining room compared to when 
measured the next day in the waiting room. However, only one initial blood pressure 
measurement with the BpTRU was measured in the examination room, and there was 
no randomization of the order of measurement conditions. 
There has been significant recent interest into research comparing attended versus 
unattended BP measurement. Several recent studies have investigated whether there is 
a difference in automated office blood pressure with and without an observer in the 
room33, 34. Results of these studies have shown no statistically significant difference in 
blood pressure between these measurement conditions This could be due to the small 
sample size (only fifty-one participants in one of the studies), or it could indicate that 
the presence of another person in the room whilst AOBP is being measured does not 
have a significant effect on blood pressure. This finding was also supported by a 
survey conducted after the conclusion of the SPRINT trail. It was found that there 
were differences in the blood pressure measurement conditions between trial sites, 
with some measuring BP with the participant unattended and some with the 
participant attended with study personnel in the room35. A post-hoc analysis found 
that similar blood pressure measurements were obtained whether the measurement 
technique used was attended or unattended.  
 
 18 
Significance  
The current recommendation for use of the BpTRU device is to measure a patient’s 
blood pressure while they are alone in a quiet room and maintaining silence. This will 
be the first study to investigate the effect on recorded blood pressure of holding a 
health-related conversation with a patient during the measurement of blood pressure 
using the BpTRU device compared to the recorded blood pressure while the patient is 
alone and maintaining silence. The results of this study will guide best practice for the 
accurate measurement of blood pressure using a BpTRU device.  
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Chapter 2: Research Question 
In adults who have their blood pressure measured using a BpTRU device in the 
primary care setting, does the presence of a healthcare professional in the examination 
room engaging the patient in a health-related conversation during the measurement 
period affect the recorded measurement of blood pressure, compared to the patient 
being alone in the examination room and silent during the measurement period? 
The hypothesis is that blood pressure measurements will be higher when measured 
whilst engaging the patient in a health-related conversation. 
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Chapter 3: Methods  
Design 
This study assessed two approaches to measuring blood pressure in the primary care 
setting using a BpTRU device in which participants serve as their own control and the 
order of testing is randomized. The study was conducted in the setting of an academic 
family practice unit in St. John’s NL, Canada, which serves an urban population. The 
target population of the study was the patient population of this family practice. 
Inclusion criteria for the study were adults aged 19 years and over with the ability to 
give informed consent to study participation. Patients with and without a diagnosis of 
hypertension were eligible for inclusion in the study. There were no exclusion criteria. 
Pregnant women were eligible to participate.  
Study participants were recruited by mail. The family practice manager provided the 
principle investigator (PI) with two lists of eligible patients of the practice, with and 
without a prior diagnosis of hypertension. The PI worked down this list, using no 
selection strategy other than the order that patients appeared on the list, and drafted 
information letters to be sent to each patient (see Appendix 1). The letter gave a brief 
outline of the study, and informed patients they could contact the PI of the study for 
more information if they wished to volunteer as a participant in the study. Each letter 
was reviewed and signed by the patient’s family doctor prior to sending. Family 
doctors were able to decline sending a letter to any of their eligible patients if they felt 
it was inappropriate for them to be contacted regarding the study at that time, for 
example if they were recently bereaved or had recently received a serious diagnosis.  
Recruitment of participants was targeted to recruit equal numbers of participants with 
and without a prior diagnosis of hypertension, and to recruit roughly equal numbers of 
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men and women to the study. When enough patients with hypertension were recruited 
only patients without hypertension were recruited from then on. The recruitment 
letters were sent in several batches throughout the recruitment and data collection 
process. As recruitment progressed the PI monitored responses to ensure balance 
between male and female participants was achieved, and sent further recruitment 
letters accordingly to the targeted sex. 
Each participants blood pressure was measured twice using a BpTRU device, once 
while alone in a room and maintaining silence and once while engaging in a health-
related conversation with the PI. Whether the participant’s blood pressure was 
measured first during conversation or during silence was randomized. Randomization 
was stratified by whether a participant had a prior diagnosis of hypertension: this was 
ascertained during the consent process before the participant was randomized to the 
order of measurement conditions. 
 Randomization was blocked in groups of eight to ensure equal numbers of 
participants in each measurement order group. Randomization was achieved by 
generation of random number sequences by the Research Coordinator of the Memorial 
University of Newfoundland Primary Healthcare Research Unit. When participants 
gave consent to participation in the study, the PI consulted the sequence to determine 
the randomization category for the participant. 
The BpTRU device was set to measure blood pressure at one-minute intervals, and 
recorded six blood pressure readings for each recording cycle. There was only a short 
period of time between the first and second blood pressure measurement cycle, in 
which time the PI explained that the participants blood pressure would be measured a 
second time in either silence or during conversation. 
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Sample Size Calculation  
As the participants serve as their own controls in this study, they are not independent. 
In order to account for the paired nature of the data, the sample size calculation for 
this study was based on a sample size equation for a test-retest study based on means.  
𝑛 =
(𝑆𝐷)2(𝑍𝛼/2 +  𝑍𝛽)
2
X̅
 
?̅? = mean of the difference between initial test and repeat test values (or the clinically 
significant difference between groups hoped to detect) 
SD = standard deviation of the mean of the difference between initial test and repeat 
test values 
 
Data used to calculate the standard deviation of the difference between paired systolic 
and diastolic blood pressure readings were taken from the CAMBO trial by Myers, 
Godwin et al36. These data were appropriate for use in this study sample size 
calculation as they comprised paired blood pressure measurements from a Canadian 
primary care patient population measured using a BpTRU device. A subset of this trial 
data was analysed, comprising the systolic and diastolic blood pressure readings of 80 
participants measured using a BpTRU device at an interval of two weeks. Blood 
pressure measurements were performed with each participant alone in a quiet room 
maintaining silence. From this analysis, the standard deviation (SD) of the difference 
between paired systolic blood pressure readings was 14.8 mmHg, and the SD of the 
difference between paired diastolic blood pressure readings was 9.58 mmHg. 
The clinically significant difference between groups for this study was set at 5 mmHg 
for systolic blood pressure, and 3 mmHg for diastolic blood pressure. 
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α = 0.05 
1-β = 0.95 
Systolic Blood Pressure 
𝑛 =
(𝑆𝐷)2 (𝑍𝛼
2
+  𝑍𝛽)
2
(X̅)2
     𝑛 =
(14.8)2(1.96 +  1.64)2
52
    𝑛 =
(219.04)(12.96)
25
 
𝑛 = 114 
Diastolic Blood Pressure 
𝑛 =
(𝑆𝐷)2 (𝑍𝛼
2
+ 𝑍𝛽)
2
(X̅)2
     𝑛 =
(9.58)2(1.96 +  1.64)2
(3)2
    𝑛 =
(91.78)(12.96)
9
 
𝑛 = 132 
 
At significance level of 0.05 and power of 95%, a sample size of 132 participants is 
sufficient to test the hypothesis that the mean difference between paired systolic blood 
pressure measurements is 5 mmHg or greater, and the mean difference between paired 
diastolic blood pressure measurements is 3 mmHg or greater. 
In order to allow for complete randomization of participants in blocks of eight, the 
study sample size was increased to 136 participants. Doubling this sample size 
allowed for subgroup analysis based on diagnosis of hypertension, provided there 
were roughly equal numbers of hypertensive and non-hypertensive participants. 
Therefore, the total sample size required for this study was two hundred and seventy-
two participants. 
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Data Collection 
All study data were collected by the PI of the study. The PI is a physician with clinical 
experience in the primary care and hospital setting. In order to simulate a primary care 
encounter as closely as possible, data were collected in a consultation room of a 
family medicine office. The PI introduced himself to participants as a doctor and 
dressed professionally in a shirt and dress pants. The PI did not wear a white coat. 
This simulated a clinical encounter between a patient and a health professional during 
the collection of study data. 
The PI was fully trained in the operation of the BpTRU device prior to initiation of the 
study. Under both study measurement conditions, the PI applied the blood pressure 
cuff, ensured the participant was sitting in the correct position, and activated the 
BpTRU device. The BpTRU device was set to take blood pressure recordings at one-
minute intervals. All six individual BpTRU recordings and the average of the last five 
recordings were noted.  
Except for diagnosis of hypertension, which was extracted from the electronic medical 
record (EMR) and displayed in the patient recruitment lists, all independent variables 
considered in the study were collected by patient self-report. The PI did not have 
access to the patient’s EMR during the study. Participant age was the only continuous 
variable collected, and categorical variables collected were sex, race, previous 
diagnosis of hypertension, taking antihypertensive medication, past medical history of 
diabetes, past medical history of ischaemic heart disease, family history of 
hypertension, family history of diabetes, family history of ischaemic heart disease, 
smoking status (never smoked or ever smoked) and excessive alcohol consumption. 
Excessive alcohol consumption was defined as greater than 14 units of alcohol per 
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week, which is the current weekly limit for men recommended by the Centre for 
Addiction and Mental Health in Canada37. A unit of alcohol is commonly defined as 5 
ounces (oz) of wine, 12 oz of beer, or 1.5 oz of distilled alcohol. The PI asked 
participants how much alcohol they drank in an average week, and then calculated 
weekly intake in units based on the response. The category “ever smoked” included 
current smokers and ex-smokers with any duration of smoking history. 
Once study participants gave their consent to participate in the study, the PI consulted 
the randomization list for the order in which to measure the participant’s blood 
pressure. The order of blood pressure measurement was randomized for each 
participant (during conversation first then alone in silence second, or alone in silence 
first and during conversation second). During the “silent” blood pressure measurement 
the participant sat in a quiet room and the PI started the BpTRU device, waited until 
the first ‘test’ blood pressure was recorded to ensure the device was working properly, 
then left the participant alone in the room while the BpTRU device completed a blood 
pressure measurement sequence. Participants were instructed to maintain silence while 
the device was measuring their blood pressure. During the “conversation” blood 
pressure measurement, the PI accompanied the participant in the room. After starting 
the BpTRU device and waiting for a successful first ‘test’ reading, the PI engaged the 
participant in conversation for the remaining measurement period by asking the 
participant a series of health-related questions. This simulated the clinical situation of 
a healthcare worker taking a history from the patient. The PI followed a standardised 
questionnaire for each conversation, which was designed to be long enough to last for 
the five minutes required by the BpTRU device to complete the measurement 
sequence (see Appendix 3). Approximately one minute elapsed between the first and 
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second blood pressure measurement cycles. All blood pressure measurements were 
conducted with the participants seated facing away from the BpTRU monitor, with 
their legs uncrossed and feet flat on the floor, and with the measurement arm resting 
on a table. 
Data were initially recorded on paper and then entered into an SPSS file stored on a 
laptop computer. The file was password protected and encrypted, and the laptop was 
password protected. Study participants were assigned a de-identified ID number, 
which was recorded on the paper data sheet and in the computer database. No 
identifying information was recorded. 
 
Data Analysis 
Data were analysed on an intention-to-treat basis. The primary outcome variables 
were systolic and diastolic blood pressure. Independent variables were measurement 
conditions of talking or silence, order of blood pressure measurement conditions, age, 
sex, race, previous diagnosis of hypertension, taking antihypertensive medication, past 
medical history of diabetes, past medical history of ischaemic heart disease, family 
history of hypertension, family history of diabetes, family history of ischaemic heart 
disease, smoking status (never smoked or ever smoked) and excessive alcohol 
consumption. 
Descriptive statistics of the study population were calculated for each independent 
variable. Categorical variables were reported as frequencies and percentages, and 
continuous variables were reported as mean and standard deviation. Descriptive 
statistics for the randomized groups of “silent first” and “talking first” were calculated 
for each independent variable, and significant differences between groups was 
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assessed for using a paired samples t-test. If significant differences between groups 
were found for an independent variable, this variable went on to be included in 
multivariate analysis. 
For systolic and diastolic blood pressure, the mean of blood pressure measurements 
taken during conversation and in silence and the difference between these 
measurements was calculated. A statistically significant difference between mean 
blood pressure measurements during silence and during conversation was assessed 
using a paired sample t-test. This process was repeated for each independent variable. 
Assessment of the association of individual independent variables on systolic and 
diastolic blood pressure without adjustment for other variables was performed using 
independent student t-test analysis. Independent variables that were found to be 
associated with systolic or diastolic blood pressure with statistical significance of p ≤ 
0.2 in univariate analysis were entered into multivariate linear regression analysis. 
Independent variables were initially entered into the model to assess the significance 
of each variable in predicting the outcome with adjustment for all other variables. 
Independent variables that no longer significantly predicted the outcome after 
adjustment were then removed from the model in a stepwise manner in the order of 
least statistical significance. At each step the impact on the overall model resulting 
from removal of each variable was assessed. If removal of a variable resulted in a 
large degree of change on the overall model (R2 > 0.1), it was deemed to be 
significantly associated with the outcome and was returned to the model. After their 
removal, each variable was then added to the model again individually to see if they 
altered the model. If it altered R2 by > 0.1 the variable was returned to the model. 
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Data analysis was carried out for all participants, and then in subgroups of participants 
with hypertension and without hypertension. Data were analysed using SPSS. 
 
Ethical Issues 
Informed consent was obtained from all participants prior to participation in the study. 
Participants were initially told that the purpose of the study was to improve the 
accuracy of blood pressure measurement using the BpTRU device. They were told 
that their blood pressure would be measured twice using the device: once while sitting 
alone in a quiet room in silence, and once while the researcher asked them some 
questions related to their health. Participants were not initially told that the purpose of 
the study was to investigate whether there was a difference in measured blood 
pressure between the two measurement conditions. The rationale for this was the 
possibility that the participant’s own expectations of what their blood pressure may be 
in each setting, or the knowledge that a change in their blood pressure was being 
assessed may have led to fluctuations in their blood pressure at the time of 
measurement which may have affected the accuracy of the study results. 
After participants completed participation in the study, there was a debrief period in 
which the participant was told the true purpose of the study. This information was 
provided in both verbal and written form (see Appendix 4). Participants were able to 
withdraw their consent for participation in the study at that time if they wished. 
Information given to potential participants before enrolment in the study otherwise 
outlined fully what they may expect from participation in the study. Individuals were 
informed that by consenting to participation in the study their blood pressure would be 
measured twice using the BpTRU device, and that each measurement consisted of six 
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contractions and relaxations of the blood pressure cuff on their arm: their blood 
pressure would be recorded twelve times in total, which comprises two BpTRU blood 
pressure measurements. Participants were also told they would be asked a series of 
questions related to their health. It was emphasised that participation in the study was 
entirely voluntary, that participants could terminate their involvement in the study at 
any time they chose, and that participation should take between 20 and 30 minutes of 
their time. It was emphasised that their decision to participate or not participate in the 
trial would have no effect on their current or future medical care. The risks of 
participation in the study outlined to patients were discomfort from the tightness of the 
blood pressure cuff on their arm, and the potential psychological distress of finding 
that they have a high blood pressure reading that they were not previously aware of. 
The outlined benefits of participation in the study were that they would be helping to 
improve the accuracy of the measurement of blood pressure using the BpTRU device 
which could result in a better standard of care for patients, and that they would be told 
what their current blood pressure measurement was. 
All participants in the study were informed of their blood pressure measurements 
orally and in writing. They were told whether their blood pressure reading was within 
normal range, higher than the normal range or lower than the normal range. It was 
emphasised to patients that if their reading was high, this did not mean they had been 
diagnosed with high blood pressure: it was explained that hypertension is diagnosed 
following more sophisticated tests and over a longer period of time. Patients with 
blood pressure readings found to be outside normal reference ranges were encouraged 
to discuss this with their family doctor. In the unlikely situation that a participant was 
found to have a dangerously high or low blood pressure reading during the study, a 
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family doctor in the clinic would be promptly notified, or the patient would be 
directed to the emergency department situated adjacent to the family medicine clinic 
in the same building. 
Participants were told how they could access the results of the study upon completion. 
This was achieved by asking interested participants to leave an email address or mail 
address with the PI, and a summary of the study results would be sent to them. This 
identifying information was kept in a separate file to the study data and not linked in 
any way to study data.  
A copy of data collected during the study is stored on a secure computer in the 
Memorial University of Newfoundland Primary Healthcare Research Unit, and will be 
kept for five years following the study. After this time, the data will be destroyed. 
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Chapter 4: Results 
Descriptive statistics for the study population are shown in Table 1, along with a 
comparison of the participants randomized to the “silent first” and “talking first” 
groups. There was a statistically significant difference in mean age and race between 
groups, so these two variables were automatically included in multivariate analysis. 
Participants were recruited between September 2015 and May 2016. One thousand 
and eighty information letters were sent out in order to achieve the required sample 
size, with a response rate of 25%. Two-hundred and seventy-two participants were 
included in the study (n=272). The study ended after the required sample size of 
participants was recruited. There was a roughly equal representation of men and 
women in the study population. 50% of the study population had a previous diagnosis 
of hypertension (n=136).  
 
 
 
 
 
 
 
 
 
  
Information letters sent 
n = 1080 
Responders recruited to study 
n = 272 
Randomized to talking first 
n = 136 
Randomized to silence first 
n = 136 
Included in analysis 
n = 136 
Included in analysis 
n = 136 
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The difference in mean blood pressure during conversation and silence is shown in 
Table 2. A statistically significant difference in both mean systolic and diastolic blood 
pressure measurements was found between talking and silent measurement conditions. 
In analysis of all participants, mean systolic blood pressure was 9 mmHg (95% CI 8.2 
– 10.5) higher when measured during conversation, and mean diastolic blood pressure 
was 8 mmHg (95% CI 7.6 – 8.9) higher when measured during conversation.  
Table 3 shows the effect of independent variables on systolic and diastolic blood 
pressure. Silent or talking measurement conditions and past medical history of 
hypertension had a significant effect (p<0.05) on systolic blood pressure. 
Measurement order, sex and excessive alcohol consumption were associated with 
systolic blood pressure with a p-value of <0.2 and were therefore included in 
multivariate analysis.  
Silent or talking measurement conditions, excessive alcohol consumption, past 
medical history of diabetes, past medical history of ischemic heart disease and family 
history of hypertension had a significant (p<0.05) effect on diastolic blood pressure in 
univariate analysis. Sex was associated with diastolic blood pressure with a p-value of 
<0.2 and was therefore included in multivariate analysis. 
The results of multivariate analysis are shown in Table 4. Measurement condition of 
talking or silence had a significant effect on both systolic and diastolic blood pressure 
after adjustment for all other variables included in multivariate analysis (p<0.000). 
With adjustment for all variables, mean systolic blood pressure increased by 9 mmHg 
when measured during conversation and diastolic blood pressure increased by 8 
mmHg when measured during conversation.  
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The increase in systolic and diastolic blood pressure seen during conversation was 
also statistically significant in subgroup analysis of participants with and without a 
previous diagnosis of hypertension. In participants with a prior diagnosis of 
hypertension, the mean blood pressure increase seen during conversation was 8 
mmHg for both systolic and diastolic blood pressure. In participants without a prior 
diagnosis of hypertension, the mean blood pressure increase seen during conversation 
was 10 mmHg for systolic blood pressure and 9 mmHg for diastolic blood pressure.  
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Table 1. Characteristics of Study Population 
 All Participants 
n = 272 
Silent First 
n = 135 
Talking First 
n = 137 
Variable Mean (SD) Mean (SD) Mean (SD) 
Age (years)* 64.6 (12.2) 62.8 (12.2) 66.4 (12.1) 
   
Variable n (%) n (%) n (%) 
Sex Female 142 (52.2) 75 (55.6) 67 (48.9) 
Male 130 (47.8) 60 (44.4) 70 (51.1) 
   
Race* Caucasian 264 (97.0) 135 (100.0) 129 (94.2) 
Other 8 (3.0) 0 (0.0) 8 (5.8) 
   
Hypertension Yes 136 (50.0) 67 (49.6) 69 (50.4) 
No 136 (50.0) 68 (50.4) 68 (49.6) 
   
Antihypertensive 
Medication 
Yes 131 (48.2) 66 (48.9) 65 (47.4) 
No 141 (51.8) 69 (51.1) 72 (52.6) 
   
Diabetes Yes 27 (9.9) 12 (8.9) 15 (10.9) 
No 245 (90.1) 123 (91.1) 122 (89.1) 
   
IHD Yes 29 (10.7) 12 (8.9) 17 (12.2) 
No 243 (89.3) 123 (91.1) 120 (87.8) 
   
FH Hypertension Yes 164 (60.3) 82 (60.7) 82 (59.9) 
No 108 (39.7) 53 (39.3) 55 (40.1) 
   
FH Diabetes Yes 120 (44.1) 60 (44.4) 60 (43.8) 
No 152 (55.9) 75 (55.6) 77 (56.2) 
   
FH IHD Yes 149 (54.8) 70 (51.9) 79 (57.7) 
No 123 (45.2) 65 (48.1) 58 (42.3) 
   
Ever smoked Yes 128 (47.1) 61 (45.2) 67 (48.9) 
No 144 (52.9) 74 (54.8) 70 (51.1) 
   
Excessive Alcohol 
Consumption 
Yes 73 (26.8) 34 (25.2) 39 (28.5) 
No 199 (73.2) 101 (74.8) 98 (71.5) 
IHD - ischemic heart disease; FH – family history 
* = p <0.05 
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Table 2.1. Mean Difference in Systolic Blood Pressure between Conversation and Silence Periods 
PMH – past medical history; IHD – ischemic heart disease; FH – family history  
 
Systolic BP  
Conversation 
Mean (SD) 
Systolic BP  
Silence 
Mean (SD) 
BP Increase 
During 
Conversation 
(95% CI) 
p value 
Full Study Population N=272 130.1 (17.6) 120.8 (15.0) 9.3 (8.2 - 10.5) <0.001 
 
Order 
Silence 
First 
127.8 (18.4) 121.0 (14.7) 6.8 (5.1 - 8.5) <0.001 
Talking 
First 
132.4(16.6) 120.6(14.4) 11.8 (10.3 - 13.2) <0.001 
 
Sex 
Male 128.4 (16.9) 120.4(14.4) 7.9 (6.5 - 9.5) <0.001 
Female  131.7 (18.2) 121.2 (15.6) 10.5 (8.7 - 12.3) <0.001 
 
PMH 
Hypertension 
Yes 133.5 (17.0) 125.1 (14.2) 8.4 (6.7 - 10.1) <0.001 
No 126.7 (17.7) 116.5 (14.5) 10.3 (8.7 - 11.8) <0.001 
 
Antihypertensive 
medication 
Yes 132.8 (17.3) 124.7 (14.8) 8.1 (6.4 - 9.8) <0.001 
No 127.6 (17.9) 117.2 (14.3) 10.5 (8.9 - 12.2) <0.001 
 
PMH Diabetes 
Yes 131.6 (17.3) 123.7 (14.2) 7.9 (4.2 – 11.6) <0.001 
No 130.0 (17.7) 120.5 (15.1) 9.5 (8.2 – 10.7) <0.001 
PMH IHD 
Yes 130.3 (16.0) 122.6 (17.7) 7.7 (4.3 – 11.1) <0.001 
No 130.1 (17.9) 120.6 (14.7) 9.5 (8.3 – 10.7) <0.001 
 
FH 
Hypertension 
Yes 130.8 (18.1) 121.0 (15.0) 9.7 (8.2 – 11.2) <0.001 
No 129.2 (16.9) 120.4 (15.0) 8.7 (6.9 – 10.6) <0.001 
FH Diabetes 
Yes 130.5 (16.1) 121.1 (13.8) 9.4 (7.7 – 11.1) <0.001 
No 129.8 (18.8) 120.6 (15.9) 9.3 (7.7 – 10.8) <0.001 
FH IHD 
Yes 130.7 (17.6) 120.7 (14.0) 10.0 (8.4 – 11.5) <0.001 
No 129.5 (17.8) 120.9 (16.2) 8.5 (6.8 – 10.3) <0.001 
 
Ever Smoked 
Yes 130.6 (17.3) 121.1 (15.0) 9.5 (7.8 - 11.2) <0.001 
No 129.7 (17.9) 120.5 (15.0) 9.1 (7.5 - 10.7) <0.001 
 
Excessive 
alcohol 
consumption 
Yes 132.3 (17.7) 122.3 (15.1) 10.0 (7.8 – 12.3) <0.001 
No 129.3 (17.6) 120.3 (15.0) 9.1 (7.7 – 10.4) <0.001 
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Table 2.2. Mean Difference in Diastolic Blood Pressure between Conversation and Silence Periods 
PMH – past medical history; IHD – ischemic heart disease; FH – family history  
 
Diastolic BP  
Conversation 
Mean (SD) 
Diastolic BP 
Silence 
Mean (SD) 
BP Increase 
During 
Conversation 
95% CI 
p value 
Full Study Population N=272 81.2 (10.8) 72.9 (9.7) 8.3 (7.6 – 8.9) <0.001 
 
Order 
Silence First 80.9 (11.1) 73.5 (9.9) 7.4 (6.4 – 8.3) <0.001 
Talking First 81.5 (10.4) 72.3 (9.5) 9.1 (8.3 – 10.0) <0.001 
 
Sex 
Male 81.6 (10.9) 74.1 (9.8) 7.5 (6.5 – 8.5) <0.001 
Female  80.8 (10.7) 71.8 (9.5) 9.0 (8.1 – 9.9) <0.001 
 
PMH 
Hypertension 
Yes 81.4 (10.5) 73.8 (9.7) 7.6 (6.6 – 8.5) <0.001 
No 81.0 (11.0) 72.0 (9.6) 9.0 (8.1 – 9.9) <0.001 
 
Antihypertensive 
Medication  
Yes 80.4 (11.0) 72.9 (10.2) 7.5 (6.5 – 8.5) <0.001 
No 81.9 (10.5) 72.9 (9.2) 9.0 (8.1 – 9.9) <0.001 
 
PMH diabetes 
Yes 76.0 (10.0) 69.0 (7.8) 7.0 (5.0 – 9.0) <0.001 
No 81.7 (10.7) 73.3 (9.8) 8.4 (7.7 – 9.1) <0.001 
PMH IHD 
Yes 74.8 (9.4) 67.8 (7.8) 7.1 (5.1 – 9.0) <0.001 
No 81.9 (10.7) 73.5 (9.7) 8.4 (7.7 – 9.1) <0.001 
 
FH 
Hypertension 
Yes 81.9 (10.8) 73.7 (9.6) 8.2 (7.4 – 9.1) <0.001 
No 80.0 (10.7) 71.6 (9.7) 8.4 (7.4 – 9.4) <0.001 
FH Diabetes 
Yes 81.2 (10.5) 73.2 (9.3) 8.0 (7.0 – 8.9) <0.001 
No 81.2 (11.0) 72.7 (10.0) 8.5 (7.6 – 9.4) <0.001 
FH IHD 
Yes 81.7 (10.4) 73.1 (9.4) 8.6 (7.8 – 9.5) <0.001 
No 80.5 (11.2) 72.7 (10.0) 7.8 (6.8 – 8.9) <0.001 
 
Ever Smoked 
Yes 81.2 (10.8) 72.6 (9.8) 8.6 (7.6 – 9.5) <0.001 
No 81.2 (10.8) 73.2 (9.6) 8.0 (7.1 – 8.9) <0.001 
 
Excessive 
Alcohol 
Consumption 
Yes 84.0 (11.1) 74.8 (10.2) 9.2 (7.9 – 10.6) <0.001 
No 80.1 (10.5) 72.2 (9.4) 7.9 (7.2 – 8.7) <0.001 
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Table 3. Effect of Independent Variables on Mean Blood Pressure 
PMH – past medical history; IHD – ischemic heart disease; FH – family history 
p value <0.2 (bold font): included in multivariate analysis  
 
Systolic BPTRU 
Mean (SD) 
P Value 
Diastolic 
BPTRU 
Mean (SD) 
t-test  
p value 
Measuring 
Condition 
Talking 130.1 (17.6) 
<0.001 
81.2 (10.8) 
<0.001 
Silence 120.8 (15.0) 72.9 (9.7) 
 
Order 
Talking 
First 
126.5 (17.0) 
0.160 
76.9 (11.0) 
0.774 
Silent First 124.4 (17.0) 77.2 (11.1) 
 
Sex 
Female 126.4 (17.7) 
0.169 
76.3 (11.0) 
0.098 
Male 124.4 (16.2) 77.9 (11.0) 
 
PMH 
Hypertension 
Yes 129.3 (16.2) 
<0.001 
77.6 (10.8) 
0.270 
No 121.6 (17.0) 76.5 (11.3) 
 
Antihypertensive 
Medication 
Yes 129.6 (16.3) 
0.462 
76.6 (11.2) 
0.421 
No 127.2 (15.0) 77.4 (10.9) 
 
Ever Smoked 
Yes 125.9 (16.9) 
0.588 
76.9 (11.1) 
0.736 
No 125.1 (17.2) 77.2 (11.0) 
 
Excess Alcohol 
Consumption 
Yes 127.3 (17.2) 
0.132 
79.4 (11.6) 
0.003 
No 124.8 (16.9) 76.2 (10.7) 
 
PMH diabetes 
Yes 127.6 (16.1) 
0.306 
72.5 (9.6) 
0.001 
No 125.2 (17.1) 77.5 (11.1) 
 
PMH IHD 
Yes 126.5 (17.1) 
0.639 
71.3 (9.3) 
<0.001 
No 125.3 (17.0) 77.7 (11.0) 
 
FH Hypertension 
Yes 125.9 (17.3) 
0.461 
77.8 (11.0) 
0.038 
No 124.8 (16.6) 75.8 (11.0) 
 
FH Diabetes 
Yes 125.8 (15.7) 
0.700 
77.2 (10.7) 
0.776 
No 125.2 (18.0) 76.9 (11.3) 
 
FH IHD 
Yes 125.7 (16.7) 
0.748 
77.4 (10.8) 
0.393 
No 125.2 (17.5) 76.6 (11.3) 
 38 
Table 4.1 Effect of Measurement Condition on Mean Systolic Blood Pressure After 
Controlling for Some Associated Factors, Multiple Linear Regression 
 
Model Variable Coefficient  Standard Error p value  
(Constant) 105.548 3.718 0.000 
Measurement Condition 9.316 1.354 0.000 
PMH Hypertension 6.524 1.406 0.000 
Age 0.186 0.058 0.001 
PMH – past medical history 
 
Table 4.2 Effect of Measurement Condition on Mean Diastolic Blood Pressure After 
Controlling for Some Associated Factors, Multiple Linear Regression  
 
Model Variable Coefficient Standard Error p value 
(Constant) 81.988 2.459 0.000 
Age -0.174 0.035 0.000 
Measurement Conditions 8.272 0.818 0.000 
Sex 1.743 0.844 0.039 
Excessive Alcohol 3.466 0.938 0.000 
PMH Diabetes -3.444 1.399 0.014 
PMH IHD -5.499 1.381 0.000 
FH Hypertension 2.216 0.849 0.009 
PMH – past medical history; IHD – ischemic heart disease; FH – family history 
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Chapter 5: Discussion 
Holding a health-related conversation with participants during the measurement of 
their blood pressure with a BpTRU device resulted in a clinically significant increase 
in mean systolic and diastolic blood pressures. The mean increase in blood pressure 
whilst measured during conversation was 9/8 mmHg. This increase remained after 
adjustment for the independent variables measured, and was seen in participants with 
and without a previous diagnosis of hypertension. The results of this study can be 
applied to adult men and women, with and without hypertension, and should be 
generalizable to the patient populations of most primary care clinics. The increases in 
blood pressure seen during conversation in this study are similar to those reported in 
previous studies, which adds strength to the findings of this study. 
This finding has significant implications for clinical practice. It is currently 
recommended that patients’ blood pressure be measured with a BpTRU device whilst 
they are alone in a room and maintaining silence. This study supports this 
recommendation, finding that mean systolic and diastolic blood pressures measured 
during conversation are increased by a clinically significant margin. If this 
recommendation is not followed and blood pressure is measured whilst engaging 
patients in conversation, many patients may be incorrectly diagnosed with 
hypertension or overtreated for hypertension. This has the potential to create several 
adverse outcomes. It may contribute to increased spending costs with patients being 
started on antihypertensive medications unnecessarily and being brought back for 
unnecessary visits. It may lead to overtreatment of hypertension, which could expose 
patients to unnecessary treatment or side effects from antihypertensive medication. 
Overtreatment of hypertension is a significant concern in the elderly population, and 
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can lead to dizziness, orthostatic hypotension and falls, which in turn are a significant 
cause of morbidity and mortality in this patient population. 
In multivariate analysis, age also had a significant effect on mean systolic and 
diastolic blood pressure. As age increased, mean systolic blood pressure increased and 
mean diastolic blood pressure decreased. This is consistent with data from the 
Framingham Heart Study, which found that systolic blood pressure rises from age 30 
to 84 and after, and that diastolic blood pressure increases until the fifth decade then 
slowly decreases thereafter38.  
Past medical history of hypertension had a significant effect on systolic blood 
pressure. Participants with a past medical history of hypertension had significantly 
higher systolic blood pressure than participants without a past medical history of 
hypertension. Sex had a significant effect on diastolic blood pressure, with male 
participants having significantly higher diastolic blood pressure than female 
participants.  
Past medical history of diabetes, past medical history of ischemic heart disease, family 
history of hypertension and excessive alcohol intake were also found to have a 
significant effect on diastolic blood pressure. Because they were not also found to 
have a significant effect on systolic blood pressure, and because the self-reported data 
collection of these variables is less reliable, these findings should be interpreted with 
caution. 
Notably, the order of measurement of blood pressure did not significantly affect mean 
blood pressure. This suggests that blood pressure measurements do not significantly 
differ if recorded at the beginning of the visit or at a later stage during the visit. 
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 There were a number of limitations to this study which should be highlighted. Firstly, 
the design of the study compared measuring blood pressure whilst holding a health-
related conversation with the patient against measuring blood pressure while the 
patient sat alone in a quiet room in silence. This experimental design does not allow 
distinction between just “sitting in silence” or “sitting alone in silence” as the factor 
which results in any change in blood pressure. To address this, the experimental 
design could have included a three-way comparison between the patient conditions of 
“sitting alone in silence”, “sitting in silence, but with the PI in the room” and “holding 
a health-related conversation”. Whilst this experimental design may allow for a clearer 
distinction of whether it is the presence of another person in the room or the act of 
talking that results in changes in blood pressure, that was not the objective of this 
study. Our aim was to design a clinically relevant study which tested whether time and 
space could be saved in clinical practice by taking a history from patients whilst 
measuring their blood pressure, or whether the recommendation to measure blood 
pressure using the BpTRU with the patient alone and in silence in a quiet room should 
be followed. It may be an area of interest for further studies to investigate whether 
sitting alone in silence or sitting alone in silence in the presence of other people results 
in a clinically significant difference in blood pressure. 
During the “silence” blood pressure measurement condition, it cannot be guaranteed 
that patients followed the instruction to sit in silence after the PI left the room. No 
steps were taken to enforce this or to observe participants during this period. 
Participants may have sat alone in silence, or they may have engaged with their 
smartphone or even talked to themselves under their breath. In clinical practice, when 
we ask patients to sit in silence in a room while their blood pressure is being 
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measured, we have no way of knowing that they are actually sitting in silence; we can 
only trust that they are doing as they have been asked. Therefore, this study mirrors 
real-life clinical practice, which can be seen as a strength for clinically-relevant 
research. It is more important that the study conditions mirror the conditions of real-
life practice than taking excessive steps to ensure that patients are truly sitting in 
silence for the purposes of the study. 
Ninety-seven percent of the study population were of Caucasian race. This rather 
homogenous population reflects the population of the island of Newfoundland where 
the study was conducted, which was mostly settled by Irish and British immigrants. 
The results of this study may not be applicable to people of other ethnic backgrounds. 
In order to further investigate this, the study could be repeated with a more diverse 
patient population. 
The study design relied fully on patient self-report for data on all explanatory 
variables. Several studies have found patient self-report of diagnoses or lifestyle 
factors to be less accurate than other more rigorous forms of data collection39, 40, 41. 
Participation in the study was voluntary, which may create an unavoidable element of 
selection bias. The recruitment of patients to the study was not random, but was 
targeted to achieve roughly equal representation of men and women in the study and 
equal numbers of participants with and without hypertension. While this recruitment 
method was intentional in the design of the study in order to achieve the desired 
patient population, it may also have introduced an element of recruitment bias. 
There was a roughly four-minute period before blood pressure measurement 
commenced, during which time the PI obtained written consent from participants. 
There was no standardised amount of time before this during which participants sat 
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and rested, which is often seen in previous studies investigating the effect of talking 
on blood pressure. While this may lead to variation in the state of stress or rest in 
which participants entered the study (e.g. arrived half an hour early and sat quietly in 
the waiting room vs. stuck in traffic, running late and rushing in without a minute to 
spare) which could affect the results of the study, it does simulate the real world 
variation in which patients present to the primary care setting for blood pressure 
measurement. 
Similarly, there was only a short period of time of roughly one minute between the 
two sets of full blood pressure measurements under each measurement condition. A 
longer wash out period may have been incorporated into the study design, as there is a 
chance that the first measurement may then impact on the results of the second 
measurement. However, the possibility of this was controlled for in the study by 
randomizing the order of measurement condition and then considering measurement 
order as an independent variable in the study. In the analysis measurement order did 
not result in a significant difference in blood pressure, so we can conclude that the 
short wash out period did not have a significant effect on the study results. 
Before data analysis, it was decided to create dichotomous variables for alcohol intake 
and smoking status. For smoking status, the dichotomous variable of “ever smoked” 
compared participants who had never smoked with those who were current or past 
smokers. For alcohol intake, the dichotomous variable of “excessive alcohol” 
compared participants who reported to drink fourteen or less alcohol units per week 
with those who reported to drink fifteen or greater alcohol units per week. Greater 
than fourteen units of alcohol per week was chosen as the definition of excessive 
alcohol intake, as this is the current recommended weekly alcohol limit for men in 
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Canada. Although the current recommended weekly alcohol limit for Canadian 
women is nine drinks per week, it was decided to apply the men’s limit to both men 
and women to simplify the analysis in this study. It should be noted that it would have 
also been possible to have analysed these variables as continuous variables (average 
units of alcohol per week; total smoking pack years) or to have created different 
dichotomous variables, which may have led to different findings of the effect of 
smoking and alcohol on mean blood pressure. 
This study used only one automated office blood pressure (AOBP) monitor for the 
measurement of blood pressure, the BpTRU. The BpTRU was chosen for use in the 
study as it is a Canadian device commonly used throughout Canada, and has been 
used in prior hypertension research conducted in Canada. Unfortunately, since the 
study commenced the company producing the BpTRU have gone out of business and 
production of this device has ceased. While this study relied exclusively on the 
BpTRU, the findings of the study may be generalized to other forms of automated 
office blood pressure measurement. 
 
In conclusion, holding a health-related conversation with patients while measuring 
their blood pressure using a BpTRU device results in a clinically significant increase 
in systolic and diastolic blood pressure. To avoid inaccurate measurement of blood 
pressure which could result in overdiagnosis and overtreatment of hypertension, the 
findings of this study suggest that blood pressure measurement with the BpTRU 
device should be conducted with the patient alone and in silence. 
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Appendices 
Appendix 1 – Information Letter 
Dear (patient name), 
A masters student from the Faculty of Medicine of Memorial University of 
Newfoundland is currently conducting a medical research study in the Family 
Medicine Unit.  The purpose of this study is to improve the accuracy of blood pressure 
measurement using a BpTRU device.  The BpTRU device is the blood pressure 
machine used in our clinic. 
The student is looking for adults aged 19 years and above to volunteer as a participant 
in this study.  If you are interested, you can contact him to volunteer. 
Taking part in the study will take between 20 and 30 minutes.  You will be required to 
come to the Family Practice Unit to participate.  You will have your blood pressure 
measured twice using a BpTRU device, and you will be asked some general questions 
about your health.  You only have to participate in the study once.  All information 
you give during the study will be kept confidential.  
By participating in this research study, you will be helping to improve the accuracy of 
blood pressure measurement with the BpTRU device.  Your decision to participate or 
not will have no effect on your current or future medical care.  
If you are interested in participating, please contact the masters student by phone or 
email to arrange an appointment time.   
Masters Student Name: Douglas Dorward 
Telephone: 709-771-1803 
Email: douglas.dorward@med.mun.ca 
Yours sincerely, Doctor name  
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Appendix 2 – Health Conversation Questionnaire 
I’m going to ask you a series of questions related to your health. If you do not feel 
comfortable answering any of these questions, then you are free to answer the 
question by saying “I would rather not answer this question”. 
1) Age? Sex? 
2) Race? 
3) Do you have a diagnosis of hypertension? 
How long have you had that for? 
 
4) Do you take any medication for high blood pressure?  
 
5) Do you have any other medical problems? 
Diabetes / Ischaemic heart disease 
 
6) Do you smoke? 
Current / past / never 
Pack years 
Years since quitting 
 
7) Do you drink alcohol? 
Units/week 
 
8) Are there any medical problems which run in your family? 
Hypertension / Diabetes / Ischaemic heart disease 
 
9) What does your diet mainly consist of? 
10) How much fruit and vegetables do you eat per day? 
11) How much exercise do you normally take per week? 
12) Do you currently do anything to try to maintain your health? 
13) Do you have any worries about your health? 
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Appendix 3 – Debrief Form   
Thank you for taking part in this medical research study.  
The true purpose of this study is to see whether there is a difference in the 
measurement of your blood pressure with a BpTRU device when you are talking to 
someone about your health, compared to when you are sitting alone in a quiet room. 
I did not inform you of the true purpose of the study before your participation.  This is 
because knowing I am looking for a difference in your blood pressure between each 
measurement situation could lead to a change in your normal blood pressure.  This 
could affect the accuracy of the results. 
If you are happy for me to use your measurements and information in the study you do 
not need to do anything more.  If you would like to be informed of the results of this 
study when they are known, please leave your contact details below.  It is estimated 
that the results of this study will be known in spring 2016.  Your contact details will 
be kept private and will not be linked to the study data in any way. Your contact 
details will be securely destroyed after we have contacted you. 
Name: _______________________________________________________________ 
Address: ________________________ Email: _______________________________ 
Would you like to be contacted by mail {  } or email {  } 
If you would not like your measurements to be used in this study, please check the 
box below and sign your name. 
Now that I know the true purpose of this study, I no longer wish my information to be 
included in this study  {  } 
Signature of participant   Name printed   Year Month Day 
Signature of researcher   Name printed   Year Month Day  
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Appendix 4 – CONSORT Statement Checklist 
CONSORT 2010 checklist of information to include when 
reporting a randomised trial 
 
Section/Topic Item 
No 
Checklist item Reported 
on page 
No 
Title and abstract 
 1a Identification as a randomised trial in the title N/A 
1b Structured summary of trial design, methods, 
results, and conclusions (for specific guidance see 
CONSORT for abstracts) 
2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of 
rationale 
10 
2b Specific objectives or hypotheses 18 
Methods 
Trial design 3a Description of trial design (such as parallel, 
factorial) including allocation ratio 
19 
3b Important changes to methods after trial 
commencement (such as eligibility criteria), 
with reasons 
N/A 
Participants 4a Eligibility criteria for participants 19 
4b Settings and locations where the data were 
collected 
19 
Interventions 5 The interventions for each group with 
sufficient details to allow replication, including 
how and when they were actually administered 
20 
Outcomes 6a Completely defined pre-specified primary and 
secondary outcome measures, including how 
and when they were assessed 
24-25 
6b Any changes to trial outcomes after the trial 
commenced, with reasons 
N/A 
Sample size 7a How sample size was determined 21 
7b When applicable, explanation of any interim 
analyses and stopping guidelines 
N/A 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation 
sequence 
20 
8b Type of randomisation; details of any 
restriction (such as blocking and block size) 
20 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random 
allocation sequence (such as sequentially 
numbered containers), describing any steps 
taken to conceal the sequence until 
interventions were assigned 
20 
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 Implementation 10 Who generated the random allocation 
sequence, who enrolled participants, and who 
assigned participants to interventions 
20 
Blinding 11a If done, who was blinded after assignment to 
interventions (for example, participants, care 
providers, those assessing outcomes) and how 
N/A 
11b If relevant, description of the similarity of 
interventions 
N/A 
Statistical methods 12a Statistical methods used to compare groups for 
primary and secondary outcomes 
25 
12b Methods for additional analyses, such as 
subgroup analyses and adjusted analyses 
25 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants 
who were randomly assigned, received 
intended treatment, and were analysed for the 
primary outcome 
30 
13b For each group, losses and exclusions after 
randomisation, together with reasons 
30 
Recruitment 14a Dates defining the periods of recruitment and 
follow-up 
30 
14b Why the trial ended or was stopped 30 
Baseline data 15 A table showing baseline demographic and 
clinical characteristics for each group 
33 
Numbers analysed 16 For each group, number of participants 
(denominator) included in each analysis and 
whether the analysis was by original assigned 
groups 
33 
Outcomes and 
estimation 
17a For each primary and secondary outcome, 
results for each group, and the estimated effect 
size and its precision (such as 95% confidence 
interval) 
34 
17b For binary outcomes, presentation of both 
absolute and relative effect sizes is 
recommended 
N/A 
Ancillary analyses 18 Results of any other analyses performed, 
including subgroup analyses and adjusted 
analyses, distinguishing pre-specified from 
exploratory 
36-37 
Harms 19 All important harms or unintended effects in 
each group (for specific guidance see CONSORT for harms) 
N/A 
Discussion 
Limitations 20 Trial limitations, addressing sources of 
potential bias, imprecision, and, if relevant, 
multiplicity of analyses 
40 
Generalisability 21 Generalisability (external validity, 
applicability) of the trial findings 
38 
Interpretation 22 Interpretation consistent with results, balancing 
benefits and harms, and considering other 
relevant evidence 
43 
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Other information 
 
Registration 23 Registration number and name of trial registry N/A 
Protocol 24 Where the full trial protocol can be accessed, if 
available 
N/A 
Funding 25 Sources of funding and other support (such as 
supply of drugs), role of funders 
4 
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